Shuttle Pharmaceuticals files initial beneficial ownership statement by HRT Financial LP
SHPH•HRT Financial reports 10% stake in Shuttle Pharmaceuticals
- HRT Financial reported a 10% ownership stake in Shuttle Pharmaceuticals in a Form 3 filing dated July 13.
- The filing shows direct beneficial ownership of 60,540 shares of common stock as of July 9.
